FDA-cleared profile

BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device

Aidoc Medical, Ltd.

BriefCase-Triage CARE Multi-Triage CT analyzes contrast and non-contrast chest, abdomen, or chest/abdomen CT in adults or transitional adolescents aged 18 and older to flag suspected pneumothorax, pericardial effusion, large aortic aneurysm, or shoulder fracture/dislocation for hospital-network workflow triage; notifications and previews are for prioritization, not diagnosis.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
BriefCase-Triage CARE Multi-Triage CT analyzes contrast and non-contrast chest, abdomen, or chest/abdomen CT in adults or transitional adolescents aged 18 and older to flag suspected pneumothorax, pericardial effusion, large aortic aneurysm, or shoulder fracture/dislocation for hospital-network workflow triage; notifications and previews are for prioritization, not diagnosis.
FDA source Exact FDA submission Checked 2026-09-04
Intended users
Trained radiologists, emergency or acute-care clinicians, and hospital-network staff responsible for triage review.
FDA source Exact FDA submission Checked 2026-09-04
Care setting and population
Hospital-network CT triage workflows for adults and transitional adolescents aged 18 years and older.
FDA source Exact FDA submission Checked 2026-09-04
Workflow role
Parallel CT triage and notification support to prioritize review of suspected urgent findings.
FDA source Exact FDA submission Checked 2026-09-04
Required input
Contrast and non-contrast CT of the chest, abdomen, or chest and abdomen with the labeled acquisition and metadata conditions.
FDA source Exact FDA submission Checked 2026-09-04
Output and human action
Suspected finding flags, prioritization notifications, and key-image previews for pneumothorax, pericardial effusion, large aortic aneurysm, or shoulder fracture/dislocation.
FDA source Exact FDA submission Checked 2026-09-04
Limitations
Notifications and previews are for prioritization and are not diagnostic. Clinicians must review the full images; the cleared age, anatomy, acquisition, finding, and hospital-network limits apply.
FDA source Exact FDA submission Checked 2026-09-04

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253578
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-04
Anatomy
Chest and abdomen; pneumothorax, pericardial effusion, large aortic aneurysm, and shoulder fracture/dislocation
FDA source Exact FDA submission Checked 2026-09-04
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-02-26
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The FDA package describes return of triage flags, notifications, and key images in the hospital workflow; exact PACS/RIS, worklist, notification, and downtime behavior require local testing.
FDA source Exact FDA submission Checked 2026-09-04
Deployment and data flow
The FDA package describes a Linux-based server in a cloud environment; current hosting, service, security, network, and local operational boundaries remain unverified.
FDA source Exact FDA submission Checked 2026-09-04
Security and privacy
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

The FDA decision material does not establish the complete security posture for the exact product and deployment. Obtain architecture, identity, audit, encryption, retention, support-access, vulnerability-management, and incident-response evidence.

Training and support
Only trained radiologists, emergency or acute-care clinicians, and hospital-network staff responsible for triage review. should operate or interpret this product. Local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring and change control
Monitor K253578 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Notifications and previews are for prioritization and are not diagnostic. Clinicians must review the full images; the cleared age, anatomy, acquisition, finding, and hospital-network limits apply.
FDA source Exact FDA submission Checked 2026-09-04

Release and scope verification

Map the installed product, build, options, population, anatomy, inputs, outputs, and enabled functions to K253578 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The FDA package describes a Linux-based server in a cloud environment; current hosting, service, security, network, and local operational boundaries remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment details do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA package describes return of triage flags, notifications, and key images in the hospital workflow; exact PACS/RIS, worklist, notification, and downtime behavior require local testing.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Notifications and previews are for prioritization and are not diagnostic. Clinicians must review the full images; the cleared age, anatomy, acquisition, finding, and hospital-network limits apply.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price or product-specific reimbursement was established in the reviewed public material.

Lifecycle monitoring

Monitor K253578 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Notifications and previews are for prioritization and are not diagnostic. Clinicians must review the full images; the cleared age, anatomy, acquisition, finding, and hospital-network limits apply.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
The FDA package documents multi-triage CT verification for the four labeled suspected findings; it does not make the notifications diagnostic or establish independent outcome benefit.
FDA source Exact FDA submission Checked 2026-09-04
Reported sensitivity
Pneumothorax: 94.8% (95% CI: 89.5%-97.9%) Pericardial effusion: 96.4% (95% CI: 91.7%-98.8%) Large aortic aneurysm: 97.1% (95% CI: 92.7%-99.2%) Shoulder fracture or dislocation: 97.8% (95% CI: 93.7%-99.5%)
Public source Exact FDA submission Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
Pneumothorax: 95.9% (95% CI: 91.3%-98.5%) Pericardial effusion: 96.5% (95% CI: 92.0%-98.8%) Large aortic aneurysm: 97.2% (95% CI: 92.9%-99.2%) Shoulder fracture or dislocation: 99.3% (95% CI: 96.2%-100.0%)
Public source Exact FDA submission Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K253578 FDA evidence package for BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device

FDA 510(k) verification and validation evidence described in the exact submission · Chest and abdomen; pneumothorax, pericardial effusion, large aortic aneurysm, and shoulder fracture/dislocation

exact submission · Tested version: BriefCase-Triage CARE Multi-Triage CT · Sponsor or vendor study

K253578

Manufacturer evidence submitted for the exact FDA decision. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No public list price for the exact cleared product version was established. Obtain a written quote separating license, implementation, interfaces, compute, storage, training, support, upgrades, renewal, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
Public source Not applicable Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed CMS material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no candidate record for K253578; no exact native submission identifier match was found.
Public source Exact FDA submission Checked 2026-09-04

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-04Last searched
25Fields reviewed
10Source classes checked
20Reviewed PubMed leads
10Reviewed trial leads
0Unreviewed FDA recall leads

Screened 20 PubMed titles and 10 trial records. They concern pericardial effusion or unrelated acute-care topics and do not identify BriefCase-Triage CARE Multi-Triage CT, its tested release, or K253578; all 30 are quarantined. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-04.

Alternatives

Related tools to compare

FDA-cleared K203508

BriefCase

Aidoc Medical, Ltd.

BriefCase analyzes supported noncontrast head CT, head CTA, noncontrast cervical-spine CT, and CTPA examinations to triage suspected intracranial hemorrhage, large-vessel...

Modality
CT/CTA
Anatomy
Adult head, brain, cervical spine, pulmonary arteries, and thorax
Decision
2020-12-29